Editorial

Diphtheria Came Back. Remote Communities Are Carrying the Cost.

Gonorrhoea Is Not Disappearing. Too Many Systems Are Failing to See It.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

The Biomarker Test Cannot Wait Until Relapse

Cancer Treatment Is an Endurance Event. Stop Waiting for Patients to Lose Function.

A Licensing Deal Is Not Access. But It Decides Whether Access Is Possible.

When the Test Says Normal but the Pain Does Not

COVID Vaccines Still Kept Adults Out of Hospital. The Evidence Should Matter.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
